Exclusive Content
Essential Clinical Trial (CDE) Compliance Resources for Foreign Sponsors in China
Essential Clinical Trial (CDE) Compliance Resources for Foreign Sponsors in China | CG360-BIOTECH-RESO-050 *{margin:0;padding:0;box-sizing:border-box}
Essential Biotech Park and Incubator Resources for Foreign Life Sciences Firms in China
CG360-BIOTECH-RESO-049 — Essential Biotech Park and Incubator Resources for Foreign Life Sciences Firms in China *, *::before, *::after { box-sizing:
Essential NMPA Drug Registration Resources for Foreign Biotech Companies in China
Essential NMPA Drug Registration Resources for Foreign Biotech Companies in China | CG360-BIOTECH-RESO-048 *{margin:0;padding:0;box-sizing:border-box}
Does a foreign biotech need a local China partner to file an IND with CDE?
Does a Foreign Biotech Need a Local China Partner to File an IND with CDE? body { font-family: 'Segoe UI', Arial, sans-serif; line-height: 1.8; color:
What is the NMPA drug re-registration and renewal process for already-approved products in China?
What Is the NMPA Drug Re-Registration and Renewal Process for Already-Approved Products in China? body { font-family: 'Segoe UI', Arial, sans-serif; l
What are the key differences between NMPA Class II and Class III medical device registration in China?
What are the key differences between NMPA Class II and Class III medical device registration in China? There are over 50 distinct regulatory differenc